CNS
Price
$75.06
Change
-$0.68 (-0.90%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
3.7B
41 days until earnings call
IVZ
Price
$14.24
Change
-$0.18 (-1.25%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
7.41B
54 days until earnings call
Interact to see
Advertisement

CNS vs IVZ

Header iconCNS vs IVZ Comparison
Open Charts CNS vs IVZBanner chart's image
Cohen & Steers
Price$75.06
Change-$0.68 (-0.90%)
Volume$1.7K
Capitalization3.7B
Inves
Price$14.24
Change-$0.18 (-1.25%)
Volume$36.61K
Capitalization7.41B
CNS vs IVZ Comparison Chart
Loading...
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNS vs. IVZ commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNS is a Hold and IVZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (CNS: $75.10 vs. IVZ: $14.25)
Brand notoriety: CNS and IVZ are both not notable
Both companies represent the Investment Managers industry
Current volume relative to the 65-day Moving Average: CNS: 71% vs. IVZ: 100%
Market capitalization -- CNS: $3.7B vs. IVZ: $7.41B
CNS [@Investment Managers] is valued at $3.7B. IVZ’s [@Investment Managers] market capitalization is $7.41B. The market cap for tickers in the [@Investment Managers] industry ranges from $124.17B to $0. The average market capitalization across the [@Investment Managers] industry is $6.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNS’s FA Score shows that 1 FA rating(s) are green whileIVZ’s FA Score has 1 green FA rating(s).

  • CNS’s FA Score: 1 green, 4 red.
  • IVZ’s FA Score: 1 green, 4 red.
According to our system of comparison, CNS is a better buy in the long-term than IVZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNS’s TA Score shows that 3 TA indicator(s) are bullish while IVZ’s TA Score has 5 bullish TA indicator(s).

  • CNS’s TA Score: 3 bullish, 7 bearish.
  • IVZ’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IVZ is a better buy in the short-term than CNS.

Price Growth

CNS (@Investment Managers) experienced а -3.05% price change this week, while IVZ (@Investment Managers) price change was -3.39% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -0.29%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +1.37%.

Reported Earning Dates

CNS is expected to report earnings on Jul 16, 2025.

IVZ is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Investment Managers (-0.29% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVZ($7.41B) has a higher market cap than CNS($3.7B). CNS has higher P/E ratio than IVZ: CNS (28.73) vs IVZ (12.27). IVZ YTD gains are higher at: -15.443 vs. CNS (-17.452). IVZ has higher annual earnings (EBITDA): 1.13B vs. CNS (184M). IVZ has more cash in the bank: 1.93B vs. CNS (265M). CNS has less debt than IVZ: CNS (140M) vs IVZ (9.05B). IVZ has higher revenues than CNS: IVZ (5.72B) vs CNS (490M).
CNSIVZCNS / IVZ
Capitalization3.7B7.41B50%
EBITDA184M1.13B16%
Gain YTD-17.452-15.443113%
P/E Ratio28.7312.27234%
Revenue490M5.72B9%
Total Cash265M1.93B14%
Total Debt140M9.05B2%
FUNDAMENTALS RATINGS
CNS vs IVZ: Fundamental Ratings
CNS
IVZ
OUTLOOK RATING
1..100
5963
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
5856
SMR RATING
1..100
2882
PRICE GROWTH RATING
1..100
6161
P/E GROWTH RATING
1..100
6585
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IVZ's Valuation (18) in the Investment Managers industry is somewhat better than the same rating for CNS (60). This means that IVZ’s stock grew somewhat faster than CNS’s over the last 12 months.

IVZ's Profit vs Risk Rating (56) in the Investment Managers industry is in the same range as CNS (58). This means that IVZ’s stock grew similarly to CNS’s over the last 12 months.

CNS's SMR Rating (28) in the Investment Managers industry is somewhat better than the same rating for IVZ (82). This means that CNS’s stock grew somewhat faster than IVZ’s over the last 12 months.

CNS's Price Growth Rating (61) in the Investment Managers industry is in the same range as IVZ (61). This means that CNS’s stock grew similarly to IVZ’s over the last 12 months.

CNS's P/E Growth Rating (65) in the Investment Managers industry is in the same range as IVZ (85). This means that CNS’s stock grew similarly to IVZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNSIVZ
RSI
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
61%
Bullish Trend 23 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZGFAX19.590.04
+0.20%
American Beacon Ninety One Gbl Frnchs Y
JNPSX20.95N/A
N/A
Janus Henderson Small Cap Value D
LAMHX23.79N/A
N/A
Lord Abbett Dividend Growth R6
RGAHX77.04N/A
N/A
American Funds Growth Fund of Amer R5E
VECRX21.54N/A
N/A
Virtus KAR Equity Income R6